{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:48:18Z","timestamp":1791200898187,"version":"4.2.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ejphar.2011.04.034","type":"journal-article","created":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T01:38:57Z","timestamp":1304213937000},"page":"63-71","source":"Crossref","is-referenced-by-count":19,"title":["The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): Comparison of efficacy and side effects across rodent species"],"prefix":"10.1016","volume":"661","author":[{"given":"Sherry X.","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy A.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald H.","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kazdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha F.","family":"McCool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Bercovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginny D.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deen","family":"Tulshian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B.","family":"Varty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.04.034_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/400_2007_057","article-title":"The orphanin FQ\/nociceptin (OFQ\/N) system","volume":"46","author":"Civelli","year":"2008","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0010","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-3565(24)29443-X","article-title":"Pharmacological characterization of the novel nonpeptide orphanin FQ\/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo","volume":"298","author":"Dautzenberg","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0015","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.peptides.2007.04.012","article-title":"Altered anxiety-related behavior in nociceptin\/orphanin FQ receptor gene knockout mice","volume":"28","author":"Gavioli","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0020","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0006-8993(99)01684-4","article-title":"Orphanin FQ, a novel neuropeptide with anti-stress-like activity","volume":"836","author":"Griebel","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0028-3908(01)00048-X","article-title":"Influence of the selective ORL1 receptor agonist, 64-6198, on rodent neurological function","volume":"41","author":"Higgins","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejphar.2007.10.018","article-title":"Pharmacological properties of a novel nociceptin\/orphanin FQ receptor agonist, 2-(3,5-dimethylpiperazin-1-yl)-1-[1-(1-methylcyclooctyl)piperidin-4-yl]-1H-benzimidazole, with anxiolytic potential","volume":"579","author":"Hirao","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1254\/jphs.FP0071742","article-title":"Pharmacological characterization of the newly synthesized nociceptin\/orphanin FQ-receptor agonist 1-[1-(1-methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole as an anxiolytic agent","volume":"106","author":"Hirao","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0040","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.bmcl.2009.03.031","article-title":"The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety","volume":"19","author":"Ho","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0045","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.10.026","article-title":"Long-lasting antinociceptive spinal effects in primates of the novel nociceptin\/orphanin FQ receptor agonist UFP-112","volume":"148","author":"Hu","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0050","doi-asserted-by":"crossref","first-page":"14854","DOI":"10.1073\/pnas.94.26.14854","article-title":"Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress","volume":"94","author":"Jenck","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0055","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1073\/pnas.090514397","article-title":"A synthetic agonist at the orphanin FQ\/nociceptin receptor ORL1: anxiolytic profile in the rat","volume":"97","author":"Jenck","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jpain.2008.11.006","article-title":"Antinociceptive effects of nociceptin\/orphanin FQ administered intrathecally in monkeys","volume":"10","author":"Ko","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0065","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/npp.2009.33","article-title":"Behavioral effects of a synthetic agonist selective for nociceptin\/orphanin FQ peptide receptors in monkeys","volume":"34","author":"Ko","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0070","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1073\/pnas.96.18.10444","article-title":"Targeted disruption of the orphanin FQ\/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice","volume":"96","author":"Koster","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/sj.bjp.0705583","article-title":"Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors","volume":"141","author":"Kuzmin","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.bjp.0705401","article-title":"Partial agonist behaviour depends upon the level of nociceptin\/orphanin FQ receptor expression: studies using the ecdysone-inducible mammalian expression system","volume":"140","author":"McDonald","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000077448","article-title":"Antitussive profile of the NOP agonist Ro 64-6198 in the guinea pig","volume":"71","author":"McLeod","year":"2004","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(97)01411-8","article-title":"Nociceptin\/orphanin FQ and the opioid receptor-like ORL1 receptor","volume":"340","author":"Meunier","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0095","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0196-9781(00)00227-8","article-title":"Tissue distribution of the opioid receptor-like (ORL1) receptor","volume":"21","author":"Mollereau","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(94)80235-1","article-title":"ORL1, a novel member of the opioid receptor family\u2014cloning, functional expression and localization","volume":"341","author":"Mollereau","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2006.07.015","article-title":"A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants","volume":"547","author":"Nicolas","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2011.04.034_bb0115","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/emboj\/16.8.1858","article-title":"Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin\/orphaninFQ receptor","volume":"16","author":"Nishi","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(00)00520-3","article-title":"In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist","volume":"402","author":"Ozaki","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.034_bb0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00213-010-2012-7","article-title":"The effects of nociceptin\/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys","volume":"213","author":"Podlesnik","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0130","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: a neuropeptide that activates an opioid-like G protein- coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00213-005-0041-4","article-title":"Characterization of the nociceptin receptor (ORL-1) agonist, Ro 64-6198, in tests of anxiety across multiple species","volume":"182","author":"Varty","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2011.04.034_bb0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/jpet.108.136937","article-title":"The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)","volume":"326","author":"Varty","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911004432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911004432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T09:39:32Z","timestamp":1741167572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911004432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":28,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0014299911004432"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.04.034","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}